Excess risk of dying of other causes of cured cancer patients

Laura Botta, Gemma Gatta, Annalisa Trama, Riccardo Capocaccia

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The proportion of patients cured of cancer is usually estimated with cure models assuming they have the same death risk as the general population. These patients, even when cured, often maintain an extra death risk compared to the overall population. Our aims were to estimate this extra risk, and to take it into account in estimating cure proportions and relative survival (RS). Methods: We used RS mixture model with an additional parameter expressing the extra noncancer death risk of patients, assumed constant with age. We applied the model to the SEER registries survival data (1990–1994 diagnosed patients) with colorectal, breast, and lung cancers, and followed up to 2013. Results: The estimated relative risk of death for cured patients versus the general population was 1.11 for colorectal, 1.16 for breast, and 2.17 and 2.12, respectively, for female and male lung cancers. Taking this extra risk into account leads, for all cancers, to a higher estimated proportion of cured and a lower RS of uncured patients. In addition, it leads to a higher estimated RS for all patients aged >70 years, and for lung cancer patients aged >50 years, at diagnosis. Conclusions: Mortality of survivors not directly due to the diagnosed cancer was significantly higher than in the general population. It affected the estimates of cure proportions for all age classes and RS in the elderly.

Original languageEnglish
Pages (from-to)199-204
Number of pages6
JournalTumori
Volume105
Issue number3
DOIs
Publication statusPublished - Jun 1 2019

Fingerprint

Survival
Neoplasms
Lung Neoplasms
Population
Risk-Taking
Survivors
Registries
Colorectal Neoplasms
Breast
Breast Neoplasms
Mortality

Keywords

  • Cancer
  • cure
  • relative survival
  • SEER
  • survivors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Excess risk of dying of other causes of cured cancer patients. / Botta, Laura; Gatta, Gemma; Trama, Annalisa; Capocaccia, Riccardo.

In: Tumori, Vol. 105, No. 3, 01.06.2019, p. 199-204.

Research output: Contribution to journalArticle

Botta, Laura ; Gatta, Gemma ; Trama, Annalisa ; Capocaccia, Riccardo. / Excess risk of dying of other causes of cured cancer patients. In: Tumori. 2019 ; Vol. 105, No. 3. pp. 199-204.
@article{93684895dee24fc3b044fa4c588652dd,
title = "Excess risk of dying of other causes of cured cancer patients",
abstract = "Background: The proportion of patients cured of cancer is usually estimated with cure models assuming they have the same death risk as the general population. These patients, even when cured, often maintain an extra death risk compared to the overall population. Our aims were to estimate this extra risk, and to take it into account in estimating cure proportions and relative survival (RS). Methods: We used RS mixture model with an additional parameter expressing the extra noncancer death risk of patients, assumed constant with age. We applied the model to the SEER registries survival data (1990–1994 diagnosed patients) with colorectal, breast, and lung cancers, and followed up to 2013. Results: The estimated relative risk of death for cured patients versus the general population was 1.11 for colorectal, 1.16 for breast, and 2.17 and 2.12, respectively, for female and male lung cancers. Taking this extra risk into account leads, for all cancers, to a higher estimated proportion of cured and a lower RS of uncured patients. In addition, it leads to a higher estimated RS for all patients aged >70 years, and for lung cancer patients aged >50 years, at diagnosis. Conclusions: Mortality of survivors not directly due to the diagnosed cancer was significantly higher than in the general population. It affected the estimates of cure proportions for all age classes and RS in the elderly.",
keywords = "Cancer, cure, relative survival, SEER, survivors",
author = "Laura Botta and Gemma Gatta and Annalisa Trama and Riccardo Capocaccia",
year = "2019",
month = "6",
day = "1",
doi = "10.1177/0300891619837896",
language = "English",
volume = "105",
pages = "199--204",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Excess risk of dying of other causes of cured cancer patients

AU - Botta, Laura

AU - Gatta, Gemma

AU - Trama, Annalisa

AU - Capocaccia, Riccardo

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Background: The proportion of patients cured of cancer is usually estimated with cure models assuming they have the same death risk as the general population. These patients, even when cured, often maintain an extra death risk compared to the overall population. Our aims were to estimate this extra risk, and to take it into account in estimating cure proportions and relative survival (RS). Methods: We used RS mixture model with an additional parameter expressing the extra noncancer death risk of patients, assumed constant with age. We applied the model to the SEER registries survival data (1990–1994 diagnosed patients) with colorectal, breast, and lung cancers, and followed up to 2013. Results: The estimated relative risk of death for cured patients versus the general population was 1.11 for colorectal, 1.16 for breast, and 2.17 and 2.12, respectively, for female and male lung cancers. Taking this extra risk into account leads, for all cancers, to a higher estimated proportion of cured and a lower RS of uncured patients. In addition, it leads to a higher estimated RS for all patients aged >70 years, and for lung cancer patients aged >50 years, at diagnosis. Conclusions: Mortality of survivors not directly due to the diagnosed cancer was significantly higher than in the general population. It affected the estimates of cure proportions for all age classes and RS in the elderly.

AB - Background: The proportion of patients cured of cancer is usually estimated with cure models assuming they have the same death risk as the general population. These patients, even when cured, often maintain an extra death risk compared to the overall population. Our aims were to estimate this extra risk, and to take it into account in estimating cure proportions and relative survival (RS). Methods: We used RS mixture model with an additional parameter expressing the extra noncancer death risk of patients, assumed constant with age. We applied the model to the SEER registries survival data (1990–1994 diagnosed patients) with colorectal, breast, and lung cancers, and followed up to 2013. Results: The estimated relative risk of death for cured patients versus the general population was 1.11 for colorectal, 1.16 for breast, and 2.17 and 2.12, respectively, for female and male lung cancers. Taking this extra risk into account leads, for all cancers, to a higher estimated proportion of cured and a lower RS of uncured patients. In addition, it leads to a higher estimated RS for all patients aged >70 years, and for lung cancer patients aged >50 years, at diagnosis. Conclusions: Mortality of survivors not directly due to the diagnosed cancer was significantly higher than in the general population. It affected the estimates of cure proportions for all age classes and RS in the elderly.

KW - Cancer

KW - cure

KW - relative survival

KW - SEER

KW - survivors

UR - http://www.scopus.com/inward/record.url?scp=85067907221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067907221&partnerID=8YFLogxK

U2 - 10.1177/0300891619837896

DO - 10.1177/0300891619837896

M3 - Article

C2 - 30905274

AN - SCOPUS:85067907221

VL - 105

SP - 199

EP - 204

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -